CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson’s Disease

Published:2018 Issue:4 Volume:25 Page:201-205
ISSN:1021-7401
Container-title:Neuroimmunomodulation
language:en
Short-container-title:Neuroimmunomodulation

Author:

Bagheri Vahid,Khorramdelazad Hossein,Hassanshahi Gholamhossein,Moghadam-Ahmadi Amir,Vakilian Alireza

Publisher

S. Karger AG

Subject

Endocrine and Autonomic Systems,Neurology,Endocrinology,Immunology

Reference32 articles.

1. Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017 Mar;3:17013.

2. Barker RA, Drouin-Ouellet J, Parmar M. Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol. 2015 Sep;11(9):492–503.

3. De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, et al. Parkinson’s disease: autoimmunity and neuroinflammation. Autoimmun Rev. 2016 Oct;15(10):1005–11.

4. Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener. 2015 Oct;4(1):19.

5. Mehta SH, Tanner CM. Role of neuroinflammation in parkinson disease: the enigma continues. Mayo Clin Proc. 2016 Oct;91(10):1328–30.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?;Frontiers in Pharmacology;2024-07-12

2. Potential Exosome Biomarkers for Parkinson’s Disease Diagnosis: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-13

3. Parkinson’s Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells;Molecular Neurobiology;2024-03-23

4. Collaborative plasma biomarkers for Parkinson disease development and progression: A cross‐sectional and longitudinal study;European Journal of Neurology;2023-07-16

5. DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship;Pharmacological Reports;2023-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3